Objective: We have shown that the administration of 0.8 mg/kg of morphine (M) The order of the treatment regimens was randomized for each study and the study days were within a 12-day interval for both studies. On each ofthe main studydays, the patients were requested to eat no food after midnight, but they were allowed to ingest wa¬ ter. The patients were specifically told to ingest no caffeinecontaining beverages. The patients used their bronchodilators ac¬ cording to their regular schedule.
\^7e have previously demonstrated1 that the admin-* * istration of 0.8 nig/kg oral morphine (M) to pa¬ tients with COPD resulted in an approximately 20% increase in the maximal oxygen consumption (Vo2max).
However, this dose of M was associated with significant drowsiness and euphoria. The objective ofthe primary study was to determine whether the administration of 30 mg of M orally alone or in combination with 25 mg of promethazine (P) (Phenergan) or 10 mg of prochlor¬ perazine (PC) (Compazine) ter in a manner similar to that previously described in our labora¬ tory. 
Psychological Testing
The subjective feelings of the patient were evaluated using six¬ teen 100-mm analog scales as originally described by Bond and Lader.8 With this instrument, the subject is asked to place a verti- (Fig 2) . The increase in the Vco2max after M-P was significandy greater than that after any of the other three regimens ( Table 2 ). The administration of 25 mg of P alone had no ef¬ fect on the exercise tolerance ofthe patients (Table 5) .
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The changes in the workload, Vo2max, Vco2max, Ve, and Vt were very similar after the administration of25 mg of P and the administration of PLAC. The changes in the Vo2max, Vco2max, Ve, and Vt were all signifi¬ cantly greater after the combination of M and P than they were after PLAC or P alone. 
